AI Analysis AI Analysis of QURE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add QURE to Watchlist?
Some Reasons Why To Add QURE:
  • +218.2% price growth over the last year
  • +89.8% YTD performance
  • High gross margin of 74.1%
PDF

Red day on Monday for uniQure N.V. stock after losing 4.10%
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Apr 30, 2026 Gain 122.51%

The uniQure N.V. stock price fell by -4.10% on the last day (Monday, 22nd Jun 2026) from $46.29 to $44.39. During the last trading day the stock fluctuated 9.60% from a day low at $43.85 to a day high of $48.06. The price has risen in 5 of the last 10 days and is up by 67.83% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 3 million shares were bought and sold for approximately $124.10 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 71.94% during the next 3 months and, with a 90% probability hold a price between $48.11 and $83.94 at the end of this 3-month period.

QURE Signals & Forecast

The uniQure N.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $35.44 and $27.74. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 17, 2026, and so far it has fallen -7.83%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for uniQure N.V. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $4.21 between high and low, or 9.60%. For the last week, the stock has had daily average volatility of 9.04%.

Our recommended stop-loss: $41.92 (-5.56%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (QURE) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect uniQure N.V. to open at $45.43, and during the day (based on 14 day Average True Range), to move between $42.65 and $46.13, which gives a possible trading interval of +/-$3.48 (+/-8.15%) up or down from last closing price. If uniQure N.V. takes out the full calculated possible swing range there will be an estimated 8.15% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $46.29, some $1.90 (4.28%) from the current price of $44.39, our system finds the risk reward not very attractive.

Is uniQure N.V. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for uniQure N.V. stock to perform well in the short-term.

Current score: 1.400 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $45.43 ( 2.35%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

QURE Performance

Trading levels for QURE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 49.64 11.83%
R2 48.04 8.21%
R1 47.04 5.97%
Price 44.39
S1 43.83 -1.27%
S2 42.83 -3.51%
S3 41.22 -7.13%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 48.16 8.49%
R1 46.29 4.28%
Price 44.39
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for uniQure N.V. Stock and on which exchange is it traded?
The symbol for uniQure N.V. is QURE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell uniQure N.V. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for uniQure N.V. stock to perform well in the short-term.

How to buy uniQure N.V. Stock?
uniQure N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy uniQure N.V. Stock.

What's the current price of uniQure N.V. Stock?
As of the end of day on the Jun 22, 2026, the price of an uniQure N.V. (QURE) share was $44.39.

What is the 52-week high and low for uniQure N.V. Stock?
The 52-week high for uniQure N.V. Stock is $71.50 and the 52-week low is $8.73.

What is the market capitalization of uniQure N.V. Stock?
As of the Jun 22, 2026, the market capitalization of uniQure N.V. is 2.8B.

When is the next earnings date for uniQure N.V.?
The upcoming earnings date for uniQure N.V. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT UNIQURE N.V.
uniQure N.V
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE